SENSEX NIFTY

Herceptin

Mar 03, 2017 at 11:26 | Source: CNBC-TV18
Biocon Chief Kiran Mazumdar Shaw says India is not an outsourced services country anymore, it is an innovation and knowledge partner.
Jan 12, 2017 at 08:21 | Source: Moneycontrol.com
Bengaluru-based biopharmaceutical firm Biocon on Wednesday said US drug regulator has accepted its partners Mylans biologics license application (BLA) for the proposed biosimilar of breast cancer drug Trastuzumab through the 351(k) pathway.
Jun 04, 2016 at 15:30 | Source: PTI
Global pharma major Mylan Inc, and Biocon have confirmed the efficacy and safety of MYL-1401O, a proposed biosimilar trastuzumab co-developed by the firms, incomparison to Roche's branded Herceptin used for treatment of cancer
Apr 26, 2016 at 20:00 | Source: PTI
Biotechnology firm Biocon today said its product portfolio will not be affected by an order of the Delhi High Court that prevented the company from calling its breast cancer medicine Trastuzumab as a biosimilar of Roche's Herceptin.
Oct 12, 2015 at 19:41 | Source: PTI
These targeted medicines represent a completely new way to treat HER2-positive metastatic breast cancer, with which the company aims to help women in India live as long and as well as possible, he added.
Feb 07, 2014 at 22:27 | Source: CNBC-TV18
The Delhi High Court (HC) has thrown a wrench into plans of Biocon and Mylan to market a breast cancer drug that goes by the scientific name Trastuzumab.
Feb 04, 2014 at 09:59 | Source: PTI
The company's subsidiary Mylan Pharmaceuticals Pvt Ltd has launched the world's first trastuzumab biosimilar, which will be marketed by Mylan under the brand name Hertraz Herceptin, a company statement said.
Jan 18, 2014 at 16:21 | Source: Reuters
Bangalore-based Biocon jointly developed biosimilar trastuzumab, which received the Indian drug regulator's marketing approval in November, with US-based Mylan Inc.
Oct 01, 2012 at 13:06 | Source: Reuters
ROCHE-HERCEPTIN-CANCER-TRIAL:Cancer trials show 1 year on Roche's Herceptin is best
Apr 02, 2012 at 09:46 | Source: Reuters
In a nondescript suburb south of London, tucked away behind a big hospital, Paul Workman and fellow scientists are celebrating victory in the "World Cup" of cancer drug research for their work in discovering a stream of new medicines.
Messages on Herceptin »

savera_patn
a

Platinum Member

40 Followers

Biocon  

http://t.in.com/e6Rv Mylan and partner Biocon cleared another hurdle with their version of Roche’s breast cancer med Herceptin, one of the biggest biosim targets in the market.

8.48 PM Mar 14th

koppik

Gold Member

11 Followers

Biocon  

proposed biosimilar trastuzumab with the U.S. Food and Drug Administration (FDA), Mylan anticipates potentially being the first company to launch a biosimilar to Herceptin in the U.S." "Mylan`s proposed biosimilar trastuzumab is one of the six biologic products co-developed by Mylan and Biocon

9.06 PM Mar 13th

koppik

Gold Member

11 Followers

Biocon  

Mylan Announces Global Settlement and License Agreements with Genentech and Roche on Herceptin® Major boost for future of Biocon! http://newsroom.mylan.com/2017-03-13-Mylan-Announces-Global-Settlement-and-License-Agreements-with-Genentech-and-Roche-on-Herceptin-R

8.40 PM Mar 13th

News Flash

Platinum Member

1422 Followers

Just Posted  

Biocon CNBC-TV18 Exclusive : Co Has A Good Opportunity To Play In The Herceptin Market

10.00 AM Mar 3rd

dhruvfun

New Member

3 Followers

Biocon  

i can`t believe how people are not able to understand what biocon is !! biocon is a world class biopharma firm, that has world class talent pool of scientists!! its trastuzumab biosimilar is showing much better results than herceptin which generates 40,000 crores alone in revenue for roche!! it

10.07 AM Jan 5th

unseenvalue

Gold Member

431 Followers

Panacea Biotec  

Biosimilar Herceptin 3. Caveat: Debt is relatively high and am not too sure on the CDR status 4. Please share your views as well Disclosure: recent investment so may be biased

11.56 PM Nov 1st 2016

savera_patn
a

Platinum Member

40 Followers

Biocon  

gone from having zero approved biosimilars to three, and it seems we are only at the beginning for this burgeoning industry, with key patents for such biologic blockbusters as AbbVie’s Humira and Roche’s Herceptin set to expire.

10.55 PM Sep 14th 2016

Willwin

Platinum Member

1161 Followers

Biocon  

Mylan`s marketing application for Herceptin biosimilar accepted for review in Europe Aug 25 2016, 11:05 ET | About: Mylan Inc (MYL) | By: Douglas W. House, SA News Editor [Contact this editor with comments or a news tip] The European Medicines Agency (EMA) accepts for review the Marketing

9.18 PM Aug 25th 2016

Wire News

Platinum Member

726 Followers

News Now  

ROCHE-HERCEPTIN-CANCER-TRIAL:Cancer trials show 1 year on Roche's Herceptin is best

1.06 PM Oct 1st 2012

ramanujam11

Gold Member

24 Followers

Biocon  

Results were good.Unexpectedly better than I anticipated. Biosimilar Trastuzumab (Herceptin, Mylan alliance) commences Phase III trials in India. This seems to be a new drug which I did not know this either. It appears,they have lot more valuable molecule which are yet to be valued. KMS is silent

2.03 PM Apr 27th 2012

News across the web »
Feb 06, 2015 at 00:45 | Source: FirstPost
Follow us on
Available On